SDI clients benefit from the first anonymized patient-level views and analysis of specific
drug and medical device use by diagnosis and procedure within and between the hospital inpatient
and outpatient settings. The result is the healthcare industry’s most comprehensive and accurate
utilization measurements (location of initiation within the hospital, sequencing of care, etc.),
as well as spillover analyses from hospital initiation of therapy into the retail care setting (please see graph below).
Our hospital analytics improve marketing for SDI’s pharmaceutical, biotech, and medical/surgical
device clients, as well as research by government agencies (e.g., FDA, CDC, NIH).
Specifically, this data integration enables our clients to:
- Track initiation of therapy and sequencing of drug utilization, procedures, and medical devices during a hospital encounter (in either the inpatient or outpatient setting).
- Track drug "loading" dose by brand, including hospital and post-hospitalization modulation of therapy.
Key characteristics of SDI’s hospital database include:
- Over 500 hospitals, with 100% of inpatient and outpatient activity, including history back to 2002.
- Hospital inpatient and outpatient analyses projected to the national and regional levels.
- Monthly updates.
This integrated data can be aligned to regional and national-level marketing and sales geographies, a function unique to SDI.
Through this synthesis of anonymized data, the healthcare industry is empowered with a
newfound view of the full continuum of care, directly impacting marketing strategies and their level of success.
For more information about linking procedure volumes, facilities, and physicians/surgeons, please see our Vector One®: InSite Comprehensive Experience (VOICE™) service.
For more information, please contact us.
|